Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium

Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. Methods...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 26; no. 19; pp. 2039 - 2045
Main Authors Abbate, Antonio, Bussani, Rossana, Biondi-Zoccai, Giuseppe G.L., Santini, Daniele, Petrolini, Alessandro, Giorgio, Fabio De, Vasaturo, Fortunata, Scarpa, Susanna, Severino, Anna, Liuzzo, Giovanna, Leone, Antonio Maria, Baldi, Feliciano, Sinagra, Gianfranco, Silvestri, Furio, Vetrovec, George W., Crea, Filippo, Biasucci, Luigi M., Baldi, Alfonso
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.10.2005
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. Methods and results In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7–120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2–14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0–7.9) vs. 2.2% (1.0–5.8), respectively, P=0.42] Conclusion Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences.
AbstractList Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. Methods and results In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7–120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2–14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0–7.9) vs. 2.2% (1.0–5.8), respectively, P=0.42] Conclusion Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences.
Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium.AIMSUnfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium.In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7-120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2-14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0-7.9) vs. 2.2% (1.0-5.8), respectively, P=0.42]METHODS AND RESULTSIn order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7-120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2-14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0-7.9) vs. 2.2% (1.0-5.8), respectively, P=0.42]Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences.CONCLUSIONIschaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences.
Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7-120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2-14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0-7.9) vs. 2.2% (1.0-5.8), respectively, P=0.42] Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences.
Author Sinagra, Gianfranco
Severino, Anna
Baldi, Alfonso
Liuzzo, Giovanna
Scarpa, Susanna
Bussani, Rossana
Baldi, Feliciano
Vasaturo, Fortunata
Vetrovec, George W.
Leone, Antonio Maria
Biasucci, Luigi M.
Crea, Filippo
Santini, Daniele
Silvestri, Furio
Giorgio, Fabio De
Petrolini, Alessandro
Abbate, Antonio
Biondi-Zoccai, Giuseppe G.L.
Author_xml – sequence: 1
  givenname: Antonio
  surname: Abbate
  fullname: Abbate, Antonio
  organization: Department of Medicine, Virginia Commonwealth University MCV Campus, Richmond, VA, USA
– sequence: 2
  givenname: Rossana
  surname: Bussani
  fullname: Bussani, Rossana
  organization: Institute of Pathological Anatomy and Department of Cardiology, University of Trieste, Trieste, Italy
– sequence: 3
  givenname: Giuseppe G.L.
  surname: Biondi-Zoccai
  fullname: Biondi-Zoccai, Giuseppe G.L.
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 4
  givenname: Daniele
  surname: Santini
  fullname: Santini, Daniele
  organization: Section of Oncology, Campus Bio-Medico University, Rome, Italy
– sequence: 5
  givenname: Alessandro
  surname: Petrolini
  fullname: Petrolini, Alessandro
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 6
  givenname: Fabio De
  surname: Giorgio
  fullname: Giorgio, Fabio De
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 7
  givenname: Fortunata
  surname: Vasaturo
  fullname: Vasaturo, Fortunata
  organization: Department of Experimental Medicine and Pathology, Università ‘La Sapienza’, Rome, Italy
– sequence: 8
  givenname: Susanna
  surname: Scarpa
  fullname: Scarpa, Susanna
  organization: Department of Experimental Medicine and Pathology, Università ‘La Sapienza’, Rome, Italy
– sequence: 9
  givenname: Anna
  surname: Severino
  fullname: Severino, Anna
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 10
  givenname: Giovanna
  surname: Liuzzo
  fullname: Liuzzo, Giovanna
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 11
  givenname: Antonio Maria
  surname: Leone
  fullname: Leone, Antonio Maria
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 12
  givenname: Feliciano
  surname: Baldi
  fullname: Baldi, Feliciano
  organization: Department of Biochemistry ‘F. Cedrangolo’, Pathologic Anatomy, Second University of Naples, Naples, Italy
– sequence: 13
  givenname: Gianfranco
  surname: Sinagra
  fullname: Sinagra, Gianfranco
  organization: Institute of Pathological Anatomy and Department of Cardiology, University of Trieste, Trieste, Italy
– sequence: 14
  givenname: Furio
  surname: Silvestri
  fullname: Silvestri, Furio
  organization: Institute of Pathological Anatomy and Department of Cardiology, University of Trieste, Trieste, Italy
– sequence: 15
  givenname: George W.
  surname: Vetrovec
  fullname: Vetrovec, George W.
  organization: Department of Medicine, Virginia Commonwealth University MCV Campus, Richmond, VA, USA
– sequence: 16
  givenname: Filippo
  surname: Crea
  fullname: Crea, Filippo
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 17
  givenname: Luigi M.
  surname: Biasucci
  fullname: Biasucci, Luigi M.
  organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy
– sequence: 18
  givenname: Alfonso
  surname: Baldi
  fullname: Baldi, Alfonso
  organization: Department of Biochemistry ‘F. Cedrangolo’, Pathologic Anatomy, Second University of Naples, Naples, Italy
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17143368$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16030061$$D View this record in MEDLINE/PubMed
BookMark eNqFkkFv1DAQhS1URLcLd07IQoJTQ-04dpxjqYAWrYADoIqL5dgTrZckDraDWIkfj6ssrdQDnCyNvvfGM_NO0NHoR0DoKSWvKGnYGcxhCzqk3RlsXUWbB2hFeVkWjaj4EVoR2vBCCHl9jE5i3BFCpKDiETqmgjBCBF2h31djp4NJRYBeJ7A4u0HYY29MP0fnx1OcXIwz4EGH7xAi9h120Ww1DE6fYj1a7EYTQMcb8eSn5KOLuYbTFvAEwRVuaYF_Ot322WjvjQ7WzcNj9LDTfYQnh3eNvrx98_nisth8fHd1cb4pTCVoKqxpjTFVKZltpJAdZXVNWFnLtpEWjCGlkS3UllQtdKJilvC24twK3XSWso6t0cvFdwr-xwwxqSGPAH2vR_BzVELyhtVZuUbP74E7P4cx_02VlFdNyev_QrISNcvQswM0twNYNQWXF7hXfzefgRcHQEej-y7o0bh4x9W0YkzIzJGFM8HHGKC7Q4i6CYG6DYFaQpAl4p7EuKRTPmYK2vX_EhaL0MUEv24b5cOrPFPN1eX1N8XffxKvv34QasP-ANd2y4o
CitedBy_id crossref_primary_10_4155_fmc_09_66
crossref_primary_10_1016_j_jacc_2008_01_003
crossref_primary_10_1161_JAHA_119_012351
crossref_primary_10_1016_j_biopha_2018_03_010
crossref_primary_10_3892_ijmm_2018_3851
crossref_primary_10_1016_j_tetlet_2008_08_091
crossref_primary_10_1016_j_bbrep_2023_101463
crossref_primary_10_1016_j_mehy_2013_02_024
crossref_primary_10_1016_j_bmcl_2008_05_002
crossref_primary_10_1002_ccd_21468
crossref_primary_10_1016_j_ijcard_2015_06_008
crossref_primary_10_1371_journal_pone_0058567
crossref_primary_10_1016_j_ijcard_2005_11_025
crossref_primary_10_1097_FJC_0b013e3181a7b5b6
crossref_primary_10_1152_ajpheart_ajpheart_91438_2007
crossref_primary_10_1016_j_jacc_2008_04_025
crossref_primary_10_1016_j_ijcard_2006_08_077
crossref_primary_10_3389_fcvm_2022_1003282
crossref_primary_10_1016_j_amjcard_2018_12_019
crossref_primary_10_1007_s10557_008_6154_3
crossref_primary_10_1007_s00210_023_02904_9
crossref_primary_10_1016_j_heliyon_2021_e07561
crossref_primary_10_1056_NEJMe0708910
crossref_primary_10_1093_abbs_gmy118
crossref_primary_10_1113_expphysiol_2012_069831
crossref_primary_10_1097_FJC_0b013e3181c87e53
crossref_primary_10_1007_s10517_011_1219_x
crossref_primary_10_1038_s41420_024_01938_z
crossref_primary_10_1016_j_ahj_2010_09_025
crossref_primary_10_1155_2013_658480
crossref_primary_10_1161_CIRCRESAHA_115_308165
crossref_primary_10_1371_journal_pone_0053265
crossref_primary_10_1007_s00109_008_0362_y
crossref_primary_10_1007_s10495_006_6306_5
crossref_primary_10_1161_JAHA_112_002360
crossref_primary_10_2217_ica_09_38
crossref_primary_10_1161_CIRCIMAGING_112_979633
crossref_primary_10_1093_eurheartj_ehq446
crossref_primary_10_1016_j_ijcard_2007_03_117
crossref_primary_10_1016_j_amjcard_2009_03_019
crossref_primary_10_1016_j_nucmedbio_2011_12_008
crossref_primary_10_1097_FJC_0b013e31814b91cb
crossref_primary_10_1097_FJC_0b013e31804a5e50
crossref_primary_10_18632_oncotarget_22946
crossref_primary_10_1089_rej_2009_0941
crossref_primary_10_1016_j_amjcard_2009_12_039
crossref_primary_10_1021_jm8015014
crossref_primary_10_4103_jfsm_jfsm_25_24
crossref_primary_10_2217_fca_11_29
crossref_primary_10_3814_2009_979318
crossref_primary_10_1152_ajpheart_00144_2019
crossref_primary_10_1016_j_mcna_2007_03_005
crossref_primary_10_1016_j_amjcard_2006_08_025
crossref_primary_10_1128_JCM_05129_11
crossref_primary_10_1016_j_jacc_2007_11_062
crossref_primary_10_1002_clc_22356
crossref_primary_10_1002_jcp_25576
crossref_primary_10_1007_s10151_018_1893_z
crossref_primary_10_1016_j_jacc_2024_05_043
crossref_primary_10_1161_CIRCULATIONAHA_107_740233
Cites_doi 10.1016/S0033-0620(00)70009-0
10.1172/JCI17664
10.1056/NEJM199912233412601
10.1152/jappl.2000.88.4.1474
10.1172/JCI119656
10.1136/hrt.2003.010280
10.1016/j.jacc.2003.09.026
10.1016/S0002-9149(98)00899-6
10.1161/01.cir.0000089041.69175.9d
10.1006/jmcc.2001.1457
10.1006/jmcc.1996.0193
10.1161/01.CIR.98.2.100
10.1016/S0735-1097(01)01683-7
10.1016/S0735-1097(01)01769-7
10.1136/heart.89.10.1138
10.1016/S0735-1097(98)00041-2
10.1016/S0002-9149(01)01967-1
10.1016/j.jtcvs.2003.08.012
10.1002/jcp.10174
10.1172/JCI119452
10.1161/01.RES.0000012202.52809.40
10.1016/S0735-1097(02)02122-8
10.1084/jem.20030613
10.1053/euhj.2002.3344
10.1016/S0008-6363(02)00716-2
10.1056/NEJM200106073442303
10.1016/0735-1097(95)00089-M
10.1016/S0167-5273(01)00578-2
10.1161/01.CIR.0000133316.92316.81
10.1159/000074813
10.1038/86498
10.1136/jcp.56.9.672
10.1016/S0735-1097(02)02959-5
10.1006/jmcc.2001.1498
10.1161/01.CIR.0000030936.97158.C4
10.1073/pnas.97.18.10197
ContentType Journal Article
Copyright 2005 INIST-CNRS
Copyright Oxford University Press(England) Oct 2005
Copyright_xml – notice: 2005 INIST-CNRS
– notice: Copyright Oxford University Press(England) Oct 2005
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
DOI 10.1093/eurheartj/ehi419
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-9645
EndPage 2045
ExternalDocumentID 1193421861
1196567801
16030061
17143368
10_1093_eurheartj_ehi419
ark_67375_HXZ_5JP6BVN6_L
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
-E4
.2P
.GJ
.I3
.XZ
.ZR
08P
0R~
18M
1B1
1TH
29G
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAFWJ
AAJKP
AAJQQ
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNGD
ABNHQ
ABNKS
ABOCM
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABVGC
ABWST
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADEZT
ADGHP
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFQV
AFFZL
AFIYH
AFOFC
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGORE
AGQPQ
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJBYB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
APWMN
AQDSO
AQKUS
ASPBG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCGUY
BCRHZ
BEYMZ
BHONS
BSCLL
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IHE
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
MBLQV
MHKGH
ML0
N4W
N9A
NGC
NOMLY
NOYVH
NQ-
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OB3
OBFPC
OCZFY
ODMLO
OGROG
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RPZ
RUSNO
RW1
RXO
RZF
SEL
TCURE
TEORI
TJX
TMA
UHS
VH1
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZGI
ZKX
~91
AAYXX
CITATION
IQODW
6.Y
ABQTQ
ABSAR
ADJQC
ADRIX
AFXEN
CGR
CUY
CVF
ECM
EIF
M49
NPM
7QP
K9.
7X8
ID FETCH-LOGICAL-c461t-dcbccc4283d9868f137703278b98decc02c8be7d04bef643d05b455d6a9fd13f3
ISSN 0195-668X
IngestDate Fri Jul 11 12:14:01 EDT 2025
Mon Jun 30 06:53:03 EDT 2025
Mon Jun 30 03:28:38 EDT 2025
Thu Feb 13 05:32:21 EST 2025
Mon Jul 21 09:11:13 EDT 2025
Tue Jul 01 01:09:17 EDT 2025
Thu Apr 24 23:06:11 EDT 2025
Tue Aug 05 16:50:12 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 19
Keywords Myocardial infarction
Cyclo-oxygenase-2
Ischaemia
Remodelling
Enzyme
Biological marker
Cardiovascular disease
Myocardial disease
Phlebology
Hypoxia-inducible factor-1
Oxygenase
Tissue
Ischemia
Heart disease
Transcription factor HIF1
Oxidoreductases
Circulatory system
Artery occlusion
Cardiology
Apoptosis
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c461t-dcbccc4283d9868f137703278b98decc02c8be7d04bef643d05b455d6a9fd13f3
Notes istex:1A331A8F7D903B46D6E42898BD5A975D7A6EA8F7
href:ehi419
ark:/67375/HXZ-5JP6BVN6-L
local:ehi419
Corresponding author. Fax: +1 360 3231204. E-mail address: abbatea@yahoo.com
ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/eurheartj/article-pdf/26/19/2039/5942309/ehi419.pdf
PMID 16030061
PQID 215484673
PQPubID 29905
PageCount 7
ParticipantIDs proquest_miscellaneous_68593764
proquest_journals_215492574
proquest_journals_215484673
pubmed_primary_16030061
pascalfrancis_primary_17143368
crossref_primary_10_1093_eurheartj_ehi419
crossref_citationtrail_10_1093_eurheartj_ehi419
istex_primary_ark_67375_HXZ_5JP6BVN6_L
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-10-01
PublicationDateYYYYMMDD 2005-10-01
PublicationDate_xml – month: 10
  year: 2005
  text: 2005-10-01
  day: 01
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle European heart journal
PublicationTitleAlternate Eur Heart J
PublicationYear 2005
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
References key 20171012003013_EHI419C7
key 20171012003013_EHI419C6
key 20171012003013_EHI419C9
key 20171012003013_EHI419C8
key 20171012003013_EHI419C3
key 20171012003013_EHI419C2
key 20171012003013_EHI419C5
key 20171012003013_EHI419C4
key 20171012003013_EHI419C28
key 20171012003013_EHI419C29
key 20171012003013_EHI419C26
key 20171012003013_EHI419C27
key 20171012003013_EHI419C24
key 20171012003013_EHI419C25
key 20171012003013_EHI419C22
key 20171012003013_EHI419C23
key 20171012003013_EHI419C20
key 20171012003013_EHI419C21
key 20171012003013_EHI419C30
key 20171012003013_EHI419C19
key 20171012003013_EHI419C17
key 20171012003013_EHI419C39
key 20171012003013_EHI419C18
key 20171012003013_EHI419C15
key 20171012003013_EHI419C37
key 20171012003013_EHI419C16
key 20171012003013_EHI419C38
key 20171012003013_EHI419C1
key 20171012003013_EHI419C13
key 20171012003013_EHI419C35
key 20171012003013_EHI419C14
key 20171012003013_EHI419C36
key 20171012003013_EHI419C11
key 20171012003013_EHI419C33
key 20171012003013_EHI419C12
key 20171012003013_EHI419C34
key 20171012003013_EHI419C31
key 20171012003013_EHI419C10
key 20171012003013_EHI419C32
References_xml – ident: key 20171012003013_EHI419C22
  doi: 10.1016/S0033-0620(00)70009-0
– ident: key 20171012003013_EHI419C24
  doi: 10.1172/JCI17664
– ident: key 20171012003013_EHI419C18
  doi: 10.1056/NEJM199912233412601
– ident: key 20171012003013_EHI419C11
  doi: 10.1152/jappl.2000.88.4.1474
– ident: key 20171012003013_EHI419C16
  doi: 10.1172/JCI119656
– ident: key 20171012003013_EHI419C28
  doi: 10.1136/hrt.2003.010280
– ident: key 20171012003013_EHI419C26
  doi: 10.1016/j.jacc.2003.09.026
– ident: key 20171012003013_EHI419C17
  doi: 10.1016/S0002-9149(98)00899-6
– ident: key 20171012003013_EHI419C32
  doi: 10.1161/01.cir.0000089041.69175.9d
– ident: key 20171012003013_EHI419C10
– ident: key 20171012003013_EHI419C31
  doi: 10.1006/jmcc.2001.1457
– ident: key 20171012003013_EHI419C36
  doi: 10.1006/jmcc.1996.0193
– ident: key 20171012003013_EHI419C29
  doi: 10.1161/01.CIR.98.2.100
– ident: key 20171012003013_EHI419C5
  doi: 10.1016/S0735-1097(01)01683-7
– ident: key 20171012003013_EHI419C35
  doi: 10.1016/S0735-1097(01)01769-7
– ident: key 20171012003013_EHI419C21
  doi: 10.1136/heart.89.10.1138
– ident: key 20171012003013_EHI419C4
  doi: 10.1016/S0735-1097(98)00041-2
– ident: key 20171012003013_EHI419C19
  doi: 10.1016/S0002-9149(01)01967-1
– ident: key 20171012003013_EHI419C25
  doi: 10.1016/j.jtcvs.2003.08.012
– ident: key 20171012003013_EHI419C3
  doi: 10.1002/jcp.10174
– ident: key 20171012003013_EHI419C15
  doi: 10.1172/JCI119452
– ident: key 20171012003013_EHI419C12
  doi: 10.1161/01.RES.0000012202.52809.40
– ident: key 20171012003013_EHI419C9
  doi: 10.1016/S0735-1097(02)02122-8
– ident: key 20171012003013_EHI419C27
  doi: 10.1084/jem.20030613
– ident: key 20171012003013_EHI419C34
  doi: 10.1053/euhj.2002.3344
– ident: key 20171012003013_EHI419C1
– ident: key 20171012003013_EHI419C30
  doi: 10.1016/S0008-6363(02)00716-2
– ident: key 20171012003013_EHI419C33
  doi: 10.1056/NEJM200106073442303
– ident: key 20171012003013_EHI419C20
  doi: 10.1016/0735-1097(95)00089-M
– ident: key 20171012003013_EHI419C37
  doi: 10.1016/S0167-5273(01)00578-2
– ident: key 20171012003013_EHI419C14
  doi: 10.1161/01.CIR.0000133316.92316.81
– ident: key 20171012003013_EHI419C23
  doi: 10.1159/000074813
– ident: key 20171012003013_EHI419C38
  doi: 10.1038/86498
– ident: key 20171012003013_EHI419C7
  doi: 10.1136/jcp.56.9.672
– ident: key 20171012003013_EHI419C39
– ident: key 20171012003013_EHI419C6
  doi: 10.1016/S0735-1097(02)02959-5
– ident: key 20171012003013_EHI419C8
  doi: 10.1006/jmcc.2001.1498
– ident: key 20171012003013_EHI419C2
  doi: 10.1161/01.CIR.0000030936.97158.C4
– ident: key 20171012003013_EHI419C13
  doi: 10.1073/pnas.97.18.10197
SSID ssj0008616
Score 2.0964115
Snippet Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently...
Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear...
SourceID proquest
pubmed
pascalfrancis
crossref
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2039
SubjectTerms Actins - metabolism
Aged
Aged, 80 and over
Apoptosis
Apoptosis - physiology
Autopsy
Biological and medical sciences
Biomarkers - metabolism
Cardiology. Vascular system
Case-Control Studies
Caspase 3
Caspases - metabolism
Coronary heart disease
Coronary Stenosis - metabolism
Coronary Stenosis - pathology
Cyclo‐oxygenase‐2
Female
Heart
Humans
Hypoxia‐inducible factor‐1
Immunohistochemistry
In Situ Nick-End Labeling
Ischaemia
Male
Medical sciences
Myocardial infarction
Myocardial Infarction - pathology
Myocardial Ischemia - metabolism
Myocardial Ischemia - pathology
Myocarditis. Cardiomyopathies
Myocytes, Cardiac - pathology
Remodelling
Ventricular Remodeling - physiology
Title Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium
URI https://api.istex.fr/ark:/67375/HXZ-5JP6BVN6-L/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/16030061
https://www.proquest.com/docview/215484673
https://www.proquest.com/docview/215492574
https://www.proquest.com/docview/68593764
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKJiFeEN-UwfADQkJdaNokbvLYsk7t2ArSWjTxEiW2I4rapmpSxBD_Gf8cd7bnfmgbHy9RlA878v3sO1_ufkfIq6Th-WGQhg4TLnd8FkgnTRoMs0Cypsi4KxLMRj4dsN7IPz4PziuVX2tRS8syfct_XJlX8j9ShWsgV8yS_QfJ2kbhApyDfOEIEobjX8m4P8sAp6WjElLAclTxmRe1nPPJEr1gOH6lGtnaFMNwFppgtsBI-amOktXkS2g6FtjAPJ-XOXKUmPBH5EF2xrqb2rexyrOaXoD-A1wZEodttz6WyC5r69-PeOp02sOuYSuAZSS3boDR2Vl70NdB3kWRzKyaOOl-GKy_gWlF45X7oH1yqN46khPlmck3_BeBjYQrb8qLXHd5RoHDmCpAbNdsnWV_ic1ofQV2NTmS0ebItn-lptAsWnK5UKPyFc-_jH3T1AYt95a6tEGMqnS8x8JbZLcJexQsn3HYf2_NgJCpurv2880_cui3bnut6z43bKJdnN7fMUY3KWCaZrq-yvUbIGUIDe-Ru2YHQ9sajvdJRc4ekNunJkbjIfm5hUqqUUktKg-oxiQ1mKR5Ri0mDyggklpEUotIuEYBkXQdkVQjkq4Q-YiMjrrDdz3H1PhwuM8apSN4yjlH1j8RhSzMkADT9ZqtMI1CAcuL2-RhKlvC9VOZgfUs3CD1g0CwJMpEw8u8x2Rnls_kU0JFU7pcsFQIpFQKeSiiQCaudEXqy8hvVUn9cpRjbgjwsQ7LJNaBGF5s5RJruVTJG_vGXJO_3PDsayU4-yAMIQZNtoK4d_45Do4_ss6nAYtPqmR_Q7Krlg2eqmTvUtSxmaxF3ETXAhg13rV3I1C-fpW8tHdBT-DPv2Qm82URMyQ2bDF44olGz6pfBooezPpnf_qwPXJnNYGfk51ysZQvwCQv030F_d8GP-0e
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Infarct-related+artery+occlusion%2C+tissue+markers+of+ischaemia%2C+and+increased+apoptosis+in+the+peri-infarct+viable+myocardium&rft.jtitle=European+heart+journal&rft.au=ABBATE%2C+Antonio&rft.au=BUSSANI%2C+Rossana&rft.au=LEONE%2C+Antonio+Maria&rft.au=BALDI%2C+Feliciano&rft.date=2005-10-01&rft.pub=Oxford+University+Press&rft.issn=0195-668X&rft.volume=26&rft.issue=19&rft.spage=2039&rft.epage=2045&rft_id=info:doi/10.1093%2Feurheartj%2Fehi419&rft.externalDBID=n%2Fa&rft.externalDocID=17143368
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon